Fertility preservation in women with haematological malignancies

References

• American College of Obstetricians and Gynecologists. (2018). ACOG Committee Opinion No. 747: Gynecologic issues in children and adolescent cancer patients and survivors. Obstetrics and Gynecology, 132(2), e67–e77. https://doi.org/10.1097/AOG.0000000000002763
   PubMed Web of Science ®Google Scholar
• Anderson, R. A., Remedios, R., Kirkwood, A. A., Patrick, P., Stevens, L., Clifton-Hadley, L., Roberts, T., Hatton, C., Kalakonda, N., Milligan, D. W., McKay, P., Rowntree, C., Scott, F. M., & Johnson, P. (2018). Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin’s lymphoma (RATHL): A secondary analysis of a randomised phase 3 trial. The Lancet Oncology, 19(10), 1328–1337. https://doi.org/10.1016/S1470-2045(18)30500-X
   PubMed Web of Science ®Google Scholar
• Bedoschi, G., Navarro, P. A., & Oktay, K. (2016). Chemotherapy-induced damage to ovary: Mechanisms and clinical impact. Future Oncology, 12(20), 2333–2344. https://doi.org/10.2217/fon-2016-0176
   PubMed Web of Science ®Google Scholar
• Bedoschi, G. M., Navarro, P. A., & Oktay, K. H. (2019). Novel insights into the pathophysiology of chemotherapy-induced damage to the ovary. Panminerva Medica, 61(1), 68–75. https://doi.org/10.23736/S0031-0808.18.03494-8
   PubMed Web of Science ®Google Scholar
• Behringer, K., Breuer, K., Reineke, T., May, M., Nogova, L., Klimm, B., Schmitz, T., Wildt, L., Diehl, V., & Engert, A. (2005). Secondary amenorrhea after Hodgkin’s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: A report from the German Hodgkin’s Lymphoma Study Group. Journal of Clinical Oncology, 23(30), 7555–7564. https://doi.org/10.1200/JCO.2005.08.138
   PubMed Web of Science ®Google Scholar
• Behringer, K., Wildt, L., Mueller, H., Mattle, V., Ganitis, P., van den Hoonaard, B., Ott, H. W., Hofer, S., Pluetschow, A., Diehl, V., Engert, A., & Borchmann, P. (2010). No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Annals of Oncology, 21(10), 2052–2060. https://doi.org/10.1093/annonc/mdq066
   PubMed Web of Science ®Google Scholar
• Brouwer, J., Hazes, J. M., Laven, J. S., & Dolhain, R. J. (2015). Fertility in women with rheumatoid arthritis: Influence of disease activity and medication. Annals of the Rheumatic Diseases, 74(10), 1836–1841. https://doi.org/10.1136/annrheumdis-2014-205383
   PubMed Web of Science ®Google Scholar
• Chow, E. J., Stratton, K. L., Leisenring, W. M., Oeffinger, K. C., Sklar, C. A., Donaldson, S. S., Ginsberg, J. P., Kenney, L. B., Levine, J. M., Robison, L. L., Shnorhavorian, M., Stovall, M., Armstrong, G. T., & Green, D. M. (2016). Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: A report from the Childhood Cancer Survivor Study cohort. The Lancet Oncology, 17(5), 567–576. https://doi.org/10.1016/S1470-2045(16)00086-3
   PubMed Web of Science ®Google Scholar
• Depmann, M., Faddy, M. J., van der Schouw, Y. T., Peeters, P. H., Broer, S. L., Kelsey, T. W., Nelson, S. M., & Broekmans, F. J. (2015). The relationship between variation in size of the primordial follicle pool and age at natural menopause. The Journal of Clinical Endocrinology & Metabolism, 100(6), E845–E851. https://doi.org/10.1210/jc.2015-1298
   PubMed Web of Science ®Google Scholar
• Dittrich, R., Kliesch, S., Schüring, A., Balcerek, M., Baston-Büst, D. M., Beck, R., Beckmann, M. W., Behringer, K., Borgmann-Staudt, A., Cremer, W., Denzer, C., Diemer, T., Dorn, A., Fehm, T., Gaase, R., Germeyer, A., Geue, K., Ghadjar, P., Goeckenjan, M., … Lotz, L. (2018). Fertility preservation for patients with malignant disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) – Recommendations and statements for girls and women. Geburtshilfe und Frauenheilkunde, 78(6), 567–584. https://doi.org/10.1055/a-0611-5549
   PubMed Web of Science ®Google Scholar
• Dolmans, M. M. (2018). Recent advances in fertility preservation and counseling for female cancer patients. Expert Review of Anticancer Therapy, 18(2), 115–120. https://doi.org/10.1080/14737140.2018.1415758
   PubMed Web of Science ®Google Scholar
• Donnez, J., & Dolmans, M. M. (2014). Transplantation of ovarian tissue. Best Practice & Research. Clinical Obstetrics & Gynaecology, 28(8), 1188–1197. https://doi.org/10.1016/j.bpobgyn.2014.09.003
   PubMed Web of Science ®Google Scholar
• Gerstl, B., Sullivan, E., Koch, J., Wand, H., Ives, A., Mitchell, R., Hamad, N., & Anazodo, A. (2019). Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: A systematic review and meta-analysis. Supportive Care in Cancer, 27(12), 4451–4460. https://doi.org/10.1007/s00520-019-05020-8
   PubMed Web of Science ®Google Scholar
• Hamy, A. S., Porcher, R., Eskenazi, S., Cuvier, C., Giacchetti, S., Coussy, F., Hocini, H., Tournant, B., Perret, F., Bonfils, S., Charvériat, P., Lacorte, J. M., & Espie, M. (2016). Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: A retrospective evaluation of subsequent pregnancies. Reproductive Biomedicine Online, 32(3), 299–307. https://doi.org/10.1016/j.rbmo.2015.12.008
   PubMed Web of Science ®Google Scholar
• Howlader, N., Noone, A. M., Krapcho, M., Miller, D., Bishop, K., Altekruse, S. F., Kosary, C. L., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., Lewis, D. R., Chen, H. S., Feuer, E. J., & Cronin, K. A. (2016). SEER 8 surveillance, epidemiology and end results, Cancer Statistics Review, 1975–2013, National Cancer Institute 2016. https://seer.cancer.gov/archive/csr/1975_2013/
   Google Scholar
• International Agency for Research on Cancer. (2018). Estimated number of new cases in 2018, worldwide, females, ages 15–44. https://bit.ly/2Hhh7xb
   Google Scholar
• Lee, S. J., Schover, L. R., Partridge, A. H., Patrizio, P., Wallace, W. H., Hagerty, K., Beck, L. N., Brennan, L. V., & Oktay, K. (2006). American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Journal of Clinical Oncology, 24(18), 2917–2931. https://doi.org/10.1200/JCO.2006.06.5888
   PubMed Web of Science ®Google Scholar
• Meissner, J., Tichy, D., Katzke, V., Kühn, T., Dietrich, S., Schmitt, T., Ziepert, M., Kuhnt, E., Rixecker, T., Zorn, M., Witzens-Harig, M., Pfreundschuh, M., & Ho, A. D. (2015). Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphoma. Annals of Oncology, 26(8), 1771–1776. https://doi.org/10.1093/annonc/mdv227
   PubMed Web of Science ®Google Scholar
• Osmanağaoğlu, M. A., Usul, H., Yuluğ, E., Kesim, M., & Karahan, S. C. (2013). Hormonal and histological changes in the ovaries with high-doses of methylprednisolone administration for acute spinal cord injury: An experimental study. Journal of Obstetrics and Gynaecology, 33(6), 585–590. https://doi.org/10.3109/01443615.2013.789833
   Web of Science ®Google Scholar
• Paradisi, R., Vicenti, R., Macciocca, M., Seracchioli, R., Rossi, S., & Fabbri, R. (2016). High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma. Fertility and Sterility, 106(5), 1176–1182. https://doi.org/10.1016/j.fertnstert.2016.06.035
   PubMed Web of Science ®Google Scholar
• Peate, M., Meiser, B., Hickey, M., & Friedlander, M. (2009). The fertility-related concerns, needs and preferences of younger women with breast cancer: A systematic review. Breast Cancer Research and Treatment, 116(2), 215–223. https://doi.org/10.1007/s10549-009-0401-6
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. (2019). Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: A committee opinion. Fertility and Sterility, 112(6), 1022–1033. https://doi.org/10.1016/j.fertnstert.2019.09.013
   PubMed Web of Science ®Google Scholar
• Rodriguez-Wallberg, K. A., & Oktay, K. (2014). Fertility preservation during cancer treatment: Clinical guidelines. Cancer Management and Research, 6, 105–117. https://doi.org/10.2147/CMAR.S32380
   PubMed Web of Science ®Google Scholar
• Sanders, J. E., Hawley, J., Levy, W., Gooley, T., Buckner, C. D., Deeg, H. J., Doney, K., Storb, R., Sullivan, K., Witherspoon, R., & Appelbaum, F. R. (1996). Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood, 87(7), 3045–3052. https://doi.org/10.1182/blood.V87.7.3045.bloodjournal8773045
   PubMed Web of Science ®Google Scholar
• Santos, T. A. (2018). Temas de Medicina da Reprodução – Reprodução Medicamente Assistida. Sociedade Portuguesa de Medicina da Reprodução.
   Google Scholar
• Spears, N., Lopes, F., Stefansdottir, A., Rossi, V., De Felici, M., Anderson, R. A., & Klinger, F. G. (2019). Ovarian damage from chemotherapy and current approaches to its protection. Human Reproduction Update, 25(6), 673–693. https://doi.org/10.1093/humupd/dmz027
   PubMed Web of Science ®Google Scholar
• Swerdlow, A. J., Cooke, R., Bates, A., Cunningham, D., Falk, S. J., Gilson, D., Hancock, B. W., Harris, S. J., Horwich, A., Hoskin, P. J., Linch, D. C., Lister, A., Lucraft, H. H., Radford, J., Stevens, A. M., Syndikus, I., Williams, M. V., & England, W. & Hodgkin Lymphoma Follow-Up Group, (2014). Risk of premature menopause after treatment for Hodgkin's lymphoma. Journal of the National Cancer Institute, 106(9):dju207. https://doi.org/10.1093/jnci/dju207
   PubMedGoogle Scholar
• Trudgen, K., & Ayensu-Coker, L. (2014). Fertility preservation and reproductive health in the pediatric, adolescent, and young adult female cancer patient. Current Opinion in Obstetrics & Gynecology, 26(5), 372–380. https://doi.org/10.1097/GCO.0000000000000107
   PubMed Web of Science ®Google Scholar
• Trullás, D. M., & Diaz-García, C. (2018). Recomendaciones sobre la preservación de la fertilidade en enfermidades hematológicas. Grupo de Interés de Preservacion de la Fertilidad (GIPF). https://www.sefertilidad.net/docs/guiaSEFpreservacion.pdf
   Google Scholar
• van Dorp, W., Haupt, R., Anderson, R. A., Mulder, R. L., van den Heuvel-Eibrink, M. M., van Dulmen-den Broeder, E., Su, H. I., Winther, J. F., Hudson, M. M., Levine, J. M., & Wallace, W. H. (2018). Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: A review. Journal of Clinical Oncology, 36(21), 2169–2180. https://doi.org/10.1200/JCO.2017.76.3441
   PubMed Web of Science ®Google Scholar
• Wallace, W. H., Shalet, S. M., Crowne, E. C., Morris-Jones, P. H., & Gattamaneni, H. R. (1989). Ovarian failure following abdominal irradiation in childhood: Natural history and prognosis. Clinical Oncology, 1(2), 75–79. https://doi.org/10.1016/S0936-6555(89)80039-1
   Google Scholar
• Wallace, W. H., Thomson, A. B., & Kelsey, T. W. (2003). The radiosensitivity of the human oocyte. Human Reproduction, 18(1), 117–121. https://doi.org/10.1093/humrep/deg016
   PubMed Web of Science ®Google Scholar
• Wo, J. Y., & Viswanathan, A. N. (2009). Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. International Journal of Radiation Oncology, Biology, Physics, 73(5), 1304–1312. https://doi.org/10.1016/j.ijrobp.2008.12.016
   PubMed Web of Science ®Google Scholar